Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard Julian Jones
Richard Julian Jones
University of Texas MD Anderson Cancer Center
Immunology
Medicine
Multiple myeloma
Pomalidomide
Thalidomide
4
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Environmental pollutant induced cellular injury is reflected in exosomes from placental explants
2019
Placenta
Samantha Sheller-Miller
Enkhtuya Radnaa
Yuko Arita
Darios Getahun
Richard Julian Jones
Morgan R. Peltier
Ramkumar Menon
Show All
Source
Cite
Save
Citations (6)
HDP-101, a Novel BCMA-targeted Antibody Conjugated to α-Amanitin, is Active against Myeloma with Preferential Efficacy against Pre-clinical Models of Deletion 17p
2019
Clinical Lymphoma, Myeloma & Leukemia
Ram Kumar Singh
Richard Julian Jones
Fazal Shirazi
Samuel Hong
Hua Wang
Jie Wan
Isere Kuitase
Andreas Pahl
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (6)
Intravenous Immunoglobulin G (IVIg) Suppresses HSP70-1 and Has Potential Therapeutic Effects Against Multiple Myeloma and Lymphoma
2013
Blood
Richard Julian Jones
Richard Eric Davis
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (0)
Thalidomide, Lenalidomide and Pomalidomide Disrupt Epstein-Barr Virus (EBV) Latency: Clinical Implications
2013
Blood
Richard Julian Jones
Shannon C. Kenney
Christopher W. Dawson
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (1)
1